home / lobbying / lobbying_activities

lobbying_activities: 3008779

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id filing_uuid filing_type registrant_name registrant_id client_name filing_year filing_period issue_code specific_issues government_entities income_amount expense_amount is_no_activity is_termination received_date
3008779 3a9109a2-3f93-4ed7-adba-8c1abba28004 Q2 AMERICAN SOCIETY OF ADDICTION MEDICINE 401104864 AMERICAN SOCIETY OF ADDICTION MEDICINE 2023 second_quarter INS Advocated for increased FY24 funding for HRSA's Addiction Medicine Fellowship Program ($30M) Advocated for increased FY24 funding for HRSA's Substance Use Disorder Treatment and Recovery Loan Repayment Program ($50M) Advocated for (S. 644/H.R. 1359) the Modernizing Opioid Treatment Access Act, which would allow specially registered opioid treatment program clinicians and addiction specialist physicians to prescribe methadone for OUD that can be picked up from pharmacies, subject to federal regulation or guidance on supply of methadone for unsupervised use. Advocated for S. 1165/ HR 2400- the Reentry Act, which would allow states to provide Medicaid coverage to eligible individuals up to 30 days prior to release from incarceration Advocated for HR 3074/S.971 - Due Process Continuity of Care Act, which would amend title XIX of the Social Security Act to remove the Medicaid coverage exclusion for inmates in custody pending disposition of charges, and for other purposes. Worked on draft legislation that would provide Medicare coverage for evidence-based residential SUD services Worked on draft legislation that would make permanent a state plan amendment option related to Medicaid's IMD exclusion Supported H.R.1502 - Comprehensive Opioid Recovery Centers Reauthorization Act of 2023, in its entirety Advocated for removal of in-person evaluation requirement in proposed telemedicine rules by the DEA and worked on related draft legislation Opposed proposed changes to the STAR-LRP program in S.462 - the Mental Health Professionals Workforce Shortage Loan Repayment Act of 2023 Advocated for removal of a lifetime ban that prevents individuals convicted of a drug felony from receiving Supplemental Nutritional Assistance Program (SNAP) or Temporary Assistance for Needy Families TANF) as part of the next Farm Bill. Advocated for various substance use disorder workforce and coverage policy changes, including some of which appear in H.R. 4531, the Support for Patients and Communities Reauthorization Act. Joined coalition letter supporting S 923 - the Better Mental Health Care for Americans Act of 2023, which would expand the Mental Health Parity and Addiction Equity Act's (MHPAEA) protections to Medicare Advantage, Medicare Part D, and all of Medicaid; improve accuracy of provider directories for Medicare Advantage plans that in part combat "ghost networks;" address the longstanding problems on inadequate reimbursement rates for mental health/substance use disorder (MH/SUD) services in Medicare and Medicaid, including for integrated services; integrate MH/SUD care into primary care by increasing reimbursement and addressing cost-sharing; support the establishment of a Medicaid demonstration project for integrated mental health care for children in settings like schools, pediatric primary care practices, and community organizations; and require the Centers for Medicare and Medicaid Services (CMS) to align payments, measure access and quality, improve prevention services for mental health care, and bring together payers to transform behavioral health within primary care. Joined coalition letter of support of S. 1302 - the Resident Physician Shortage Reduction Act of 2023, which would expand the physician workforce and ensuring patients' access to quality care, as an estimated shortage of up to 124,000 primary care and specialty physicians in America is expected by 2034. This legislation would gradually raise the number of Medicare-supported GME positions by 2,000 for seven years, and a share such positions would be targeted to hospitals with diverse needs, including those in rural areas and that serve patients from health professional shortage areas (HPSAs). Joined coalition letter in support of Fiscal Year (FY) 2024 appropriations of $35 million for the U.S. Centers for Disease Control and Prevention (CDC), $25 million for the National Institutes of Health (NIH), and $1 million for the National Institute of Justice (NIJ) to conduct public health research into firearm morbidity and mortality prevention. Joined coalition letter in opposition to the Telehealth Benefit Expansion for Workers Act of 2023 (H.R. 824), which would have allowed employers to offer workers stand-alone telehealth benefits, potentially eroding comprehensive MH/SUD coverage and creating additional barriers for individuals to receive treatment. Joined coalition letter urging appropriators to approve the full authorized level of tobacco user fees and oppose any efforts to weaken or alter FDAs authority over tobacco products through the appropriations process. Advocated for certain annual increases for Medicare office based SUD bundled codes Centers For Medicare and Medicaid Services (CMS),Congressional Budget Office (CBO),Drug Enforcement Administration (DEA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Office of Natl Drug Control Policy (NDCP),SENATE,Substance Abuse & Mental Health Services Administration (SAMHSA)   50000 0 0 2023-07-18T05:49:41-04:00
Powered by Datasette · Queries took 56.624ms · Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API